108 related articles for article (PubMed ID: 25788388)
41. Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma.
Slupski MW; Szczylik C; Jasinski MK
World J Surg Oncol; 2007 Mar; 5():36. PubMed ID: 17376238
[TBL] [Abstract][Full Text] [Related]
42. Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China.
Qun W; Tao Y
Hepatogastroenterology; 2010; 57(99-100):426-9. PubMed ID: 20698202
[TBL] [Abstract][Full Text] [Related]
43. Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.
Fiebiger WC; Scheithauer W; Traub T; Kurtaran A; Gedlicka C; Kornek GV; Virgolini I; Raderer M
Scand J Gastroenterol; 2002 Feb; 37(2):222-5. PubMed ID: 11843061
[TBL] [Abstract][Full Text] [Related]
44. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma.
Kruth J; Nissen J; Ernst T; Kripp M; Lukan N; Merx K; Hofmann WK; Hochhaus A; Hofheinz RD
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1845-51. PubMed ID: 20224968
[TBL] [Abstract][Full Text] [Related]
46. [Effects of pharmacokinetic modulation chemotherapy (PMC) using oral UFT and venous 5-FU infusion as adjuvant chemotherapy for intrahepatic cholangiocellular carcinoma].
Yokoo H; Kamiyama T; Nakagawa T; Nakanishi K; Tahara M; Fukumori D; Kamachi H; Matsushita M; Todo S
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2400-3. PubMed ID: 20037436
[TBL] [Abstract][Full Text] [Related]
47. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
Aoki Y; Sato T; Watanabe M; Sasaki M; Tsuneki I; Tanaka K
Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
[TBL] [Abstract][Full Text] [Related]
48. Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials.
Subbiah IM; Subbiah V; Tsimberidou AM; Naing A; Kaseb AO; Javle M; Fu S; Hong DS; Piha-Paul S; Wheler JJ; Hess KR; Janku F; Falchook GS; Wolff RA; Kurzrock R
Oncotarget; 2013 Jan; 4(1):156-65. PubMed ID: 23391555
[TBL] [Abstract][Full Text] [Related]
49. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
[TBL] [Abstract][Full Text] [Related]
50. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma.
Uka K; Aikata H; Takaki S; Miki D; Jeong SC; Hiramatsu A; Kodama H; Shirakawa H; Kawakami Y; Takahashi S; Toyota N; Ito K; Chayama K
Liver Int; 2007 Nov; 27(9):1209-16. PubMed ID: 17919232
[TBL] [Abstract][Full Text] [Related]
51. A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer.
Sunela KL; Koskinen S; Kellokumpu-Lehtinen PL
Cancer Chemother Pharmacol; 2010 May; 66(1):59-67. PubMed ID: 19771431
[TBL] [Abstract][Full Text] [Related]
52. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
Guan YS; Qing He ; Ping Li ; Fu YC; Zhao SW
Integr Cancer Ther; 2008 Mar; 7(1):51-3. PubMed ID: 18292595
[TBL] [Abstract][Full Text] [Related]
53. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
[TBL] [Abstract][Full Text] [Related]
54. Radiotherapy and multimodality management of cholangiocarcinoma.
Urego M; Flickinger JC; Carr BI
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):121-6. PubMed ID: 10219804
[TBL] [Abstract][Full Text] [Related]
55. Intrahepatic chemotherapy for unresectable cholangiocarcinoma: review of literature and personal experience.
Massani M; Nistri C; Ruffolo C; Bonariol R; Pauletti B; Bonariol L; Caratozzolo E; Morana G; Bassi N
Updates Surg; 2015 Dec; 67(4):389-400. PubMed ID: 26468142
[TBL] [Abstract][Full Text] [Related]
56. The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.
Song S; Yang W; Tian H; Gong S; Lei C; Lv K; Lu T; Cheng Q; Yang K; Guo T
Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101788. PubMed ID: 34389530
[TBL] [Abstract][Full Text] [Related]
57. Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status.
Moriwaki T; Ishige K; Araki M; Yoshida S; Nishi M; Sato M; Yamada T; Yamamoto Y; Ozeki M; Ishida H; Yamaguchi T; Matsuda K; Murashita T; Abei M; Hyodo I
Med Oncol; 2014 Nov; 31(11):287. PubMed ID: 25316268
[TBL] [Abstract][Full Text] [Related]
58. Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines.
Iwahashi S; Ishibashi H; Utsunomiya T; Morine Y; Ochir TL; Hanaoka J; Mori H; Ikemoto T; Imura S; Shimada M
J Med Invest; 2011 Feb; 58(1-2):106-9. PubMed ID: 21372494
[TBL] [Abstract][Full Text] [Related]
59. Biliary Tract Cancers: Finding Better Ways to Lump and Split.
Kelley RK; Bardeesy N
J Clin Oncol; 2015 Aug; 33(24):2588-90. PubMed ID: 26195717
[No Abstract] [Full Text] [Related]
60. Thermo-chemo-radiotherapy for advanced bile duct carcinoma.
Kamisawa T; Tu Y; Egawa N; Karasawa K; Matsuda T; Tsuruta K; Okamoto A
World J Gastroenterol; 2005 Jul; 11(27):4206-9. PubMed ID: 16015690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
